Dynamic contrast-enhanced MRI as a predictor of programmed death ligand-1 expression in patients with oral squamous cell carcinoma

Immune checkpoint inhibitors (ICIs) targeting programmed death ligand-1 (PD-L1) are highly promising therapies for oral squamous cell carcinoma (OSCC). The assessment of PD-L1 expression may help predicting the therapeutic effect of ICIs and, thus, benefit patient selection. Contrast index (CI) para...

Descripción completa

Detalles Bibliográficos
Autores principales: Tekiki, Nouha, Fujita, Mariko, Okui, Tatsuo, Kawai, Hotaka, Oo, May Wathone, Kawazu, Toshiyuki, Hisatomi, Miki, Okada, Shunsuke, Takeshita, Yohei, Barham, Majd, Nagatsuka, Hitoshi, Yanagi, Yoshinobu, Asaumi, Jun-Ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456498/
https://www.ncbi.nlm.nih.gov/pubmed/34594419
http://dx.doi.org/10.3892/ol.2021.13039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456498/
https://www.ncbi.nlm.nih.gov/pubmed/34594419
http://dx.doi.org/10.3892/ol.2021.13039

Ejemplares similares